...
首页> 外文期刊>Angiology: the Journal of Vascular Diseases >Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex 'Real' Clinical Scenarios: A Consensus Document of the 'Campania NSTEMI Study Group'
【24h】

Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex 'Real' Clinical Scenarios: A Consensus Document of the 'Campania NSTEMI Study Group'

机译:复型疗法治疗非ST段升高心肌梗死复杂的“真实”临床情景:“Campania Nstemi研究组”的共识文件

获取原文
获取原文并翻译 | 示例

摘要

The incidence of ST-segment elevation myocardial infarction (STEMI) has significantly decreased. Conversely, the rate of non-STEMI (NSTEMI) has increased. Patients with NSTEMI have lower short-term mortality compared to patients with STEMI, whereas at long-term follow-up, the mortality becomes comparable. This might be due to the differences in baseline characteristics, including older age and a greater prevalence of comorbidities in the NSTEMI population. Although antithrombotic strategies used in patients with NSTEMI have been well studied in clinical trials and updated guidelines are available, patterns of use and outcomes in clinical practice are less well described. Thus, a panel of Italian cardiology experts assembled under the auspices of the Campania NSTEMI Study Group for comprehensive discussion and consensus development to provide practical recommendations, for both clinical and interventional cardiologists, regarding optimal management of antithrombotic therapy in patients with NSTEMI. This position article presents and discusses various clinical scenarios in patients with NSTEMI or unstable angina, including special subsets (eg, patients aged 85 years, patients with chronic renal disease or previous cerebrovascular events, and patients requiring triple therapy or long-term antithrombotic therapy), with the panel recommendations being provided for each scenario.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号